Free Trial
NASDAQ:HCWB

HCW Biologics (HCWB) Stock Price, News & Analysis

HCW Biologics logo
$4.13 -0.11 (-2.59%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$4.50 +0.37 (+8.96%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HCW Biologics Stock (NASDAQ:HCWB)

Key Stats

Today's Range
$4.05
$4.19
50-Day Range
$3.75
$8.37
52-Week Range
$3.55
$100.80
Volume
19,934 shs
Average Volume
114,647 shs
Market Capitalization
$5.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$35.00
Consensus Rating
Buy

Company Overview

HCW Biologics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

HCWB MarketRank™: 

HCW Biologics scored higher than 54% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCW Biologics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HCW Biologics has only been the subject of 1 research reports in the past 90 days.

  • Read more about HCW Biologics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCW Biologics is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about HCW Biologics' valuation and earnings.
  • Percentage of Shares Shorted

    2.84% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently decreased by 65.99%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    HCW Biologics does not currently pay a dividend.

  • Dividend Growth

    HCW Biologics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.84% of the float of HCW Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    HCW Biologics has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCW Biologics has recently decreased by 65.99%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 1 people have searched for HCWB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HCW Biologics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $305,032.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    42.70% of the stock of HCW Biologics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 2.96% of the stock of HCW Biologics is held by institutions.

  • Read more about HCW Biologics' insider trading history.
Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

HCWB Stock News Headlines

HCW Biologics Inc News (HCWB) - Investing.com
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

HCWB Stock Analysis - Frequently Asked Questions

HCW Biologics' stock was trading at $17.8440 at the beginning of the year. Since then, HCWB shares have decreased by 76.9% and is now trading at $4.13.

HCW Biologics Inc. (NASDAQ:HCWB) released its earnings results on Thursday, May, 15th. The company reported ($0.05) earnings per share (EPS) for the quarter.

Shares of HCW Biologics reverse split before market open on Friday, April 11th 2025.The 1-40 reverse split was announced on Tuesday, April 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

HCW Biologics (HCWB) raised $45 million in an IPO on Tuesday, July 20th 2021. The company issued 5,600,000 shares at $8.00 per share. EF Hutton served as the underwriter for the IPO and Revere Securities was co-manager.

Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCW Biologics investors own include Jiuzi (JZXN), Faraday Future Intelligent Electric (FFIE), AMC Entertainment (AMC), Kiora Pharmaceuticals (KPRX), Rallybio (RLYB), Adial Pharmaceuticals (ADIL) and Aridis Pharmaceuticals (ARDS).

Company Calendar

Last Earnings
5/15/2025
Today
8/04/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HCWB
CIK
1828673
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$35.00
Potential Upside/Downside
+747.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($23.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.02 million
Net Margins
-1,712.94%
Pretax Margin
-1,713.01%
Return on Equity
N/A
Return on Assets
-90.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$2.57 million
Price / Sales
2.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.08) per share
Price / Book
-0.68

Miscellaneous

Outstanding Shares
1,440,000
Free Float
825,000
Market Cap
$5.95 million
Optionable
Not Optionable
Beta
0.66

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:HCWB) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners